MARSHALL WACE, LLP: GMED position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on GMED, newest first. How the timeline and the estimate are built.
MARSHALL WACE, LLP held 188,541 GMED shares at 2026-06-30 per its 13F-HR filed 2026-08-13.
the latest 13F is the newest step
- period ended2026-06-3013F 188,541 sharesChange vs previous 13F -374,089 shares
0.01% of the 13F portfolio, value $14,896,624.
13F-HR 0001318757-26-000010 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 562,630 sharesChange vs previous 13F -413,266 shares
0.05% of the 13F portfolio, value $48,476,201.
13F-HR 0001318757-26-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 975,896 sharesChange vs previous 13F -736,013 shares
0.08% of the 13F portfolio, value $85,205,481.
13F-HR 0001318757-26-000003 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,711,909 sharesChange vs previous 13F +131,433 shares
0.11% of the 13F portfolio, value $98,041,030.
13F-HR 0001318757-25-000046 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,580,476 sharesChange vs previous 13F +747,330 shares
0.11% of the 13F portfolio, value $93,279,694.
13F-HR 0001318757-25-000034 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 833,146 sharesChange vs previous 13F -303,120 shares
0.08% of the 13F portfolio, value $60,986,286.
13F-HR 0001318757-25-000023 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 1,136,266 sharesChange vs previous 13F +486,756 shares
0.12% of the 13F portfolio, value $93,980,562.
13F-HR 0002048047-25-000005 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 649,510 sharesChange vs previous 13F not available
0.06% of the 13F portfolio, value $46,465,945.
13F-HR 0001318757-24-000018 filed by MARSHALL WACE, LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).